Tomohiko Kimura

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Topics

Ankylosing Spondylitis

Cardiovascular Risk Factors

Glycemic Control

Venous Thromboembolism

Top Venues

Journal of diabetes investigation

Diabetes, obesity & metabolism

Scientific reports

Journal of diabetes research

This page only lists publications with an associated author ORCID identifier.

Publications

Shuhei Nakanishi, Masashi Shimoda, Tomohiko Kimura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Takashi Itoh, Shigehito Mori, Taku Sasaki, Mana Ohnishi, Haruka Takenouchi, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Fuminori Tatsumi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis. Endocrine journal 71 (5) (2024)
Shuhei Nakanishi, Masashi Shimoda, Tomohiko Kimura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (7) (2024)
Shuhei Nakanishi, Masashi Shimoda, Tomohiko Kimura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (7) (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Yuka Nogami, Yoshiko Shirakiya, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice. Diabetes, obesity & metabolism 26 (6) (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Yuka Nogami, Yoshiko Shirakiya, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice. Diabetes, obesity & metabolism (2024)
Tomohiko Kimura, Masato Kubo, Kaio Takahashi, Ryo Wamata, Yuichiro Iwamoto, Hideyuki Iwamoto, Yukino Katakura, Junpei Sanada, Yoshiro Fushimi, Masashi Shimoda, Fuminori Tatsumi, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study. Journal of diabetes research 2024 (2024)
Tomohiko Kimura, Masato Kubo, Kaio Takahashi, Ryo Wamata, Yuichiro Iwamoto, Hideyuki Iwamoto, Yukino Katakura, Junpei Sanada, Yoshiro Fushimi, Masashi Shimoda, Fuminori Tatsumi, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study. Journal of diabetes research 2024 (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Masashi Shimoda, Yuichi Morimoto, Yuki Watanabe, Takashi Itoh, Taku Sasaki, Shigehito Mori, Masato Kubo, Haruka Takenouchi, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
C-peptide index at 2 h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes. Diabetes, obesity & metabolism 26 (7) (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Takashi Itoh, Shigehito Mori, Taku Sasaki, Mana Ohnishi, Haruka Takenouchi, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Fuminori Tatsumi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis. Endocrine journal (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Masashi Shimoda, Yuichi Morimoto, Yuki Watanabe, Takashi Itoh, Taku Sasaki, Shigehito Mori, Masato Kubo, Haruka Takenouchi, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
C-peptide index at 2 h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes. Diabetes, obesity & metabolism (2024)
Hideyuki Iwamoto, Tomohiko Kimura, Yoshiro Fushimi, Masahiro Iwamoto, Fuminori Tatsumi, Junpei Sanada, Yuichiro Iwamoto, Yukino Katakura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching. Diabetes, obesity & metabolism (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Yuka Nogami, Yoshiko Shirakiya, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice. Diabetes, obesity & metabolism 26 (6) (2024)
Shuhei Nakanishi, Masashi Shimoda, Tomohiko Kimura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (7) (2024)
Tomohiko Kimura, Yukino Katakura, Masashi Shimoda, Fumiko Kawasaki, Mizuho Yamabe, Fuminori Tatsumi, Michihiro Matsuki, Yuichiro Iwamoto, Takatoshi Anno, Yoshiro Fushimi, Shinji Kamei, Yukiko Kimura, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto, null null
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study). Diabetes, obesity & metabolism (2023)
Hideaki Kaneto, Tomohiko Kimura, Masashi Shimoda, Atsushi Obata, Junpei Sanada, Yoshiro Fushimi, Taka-Aki Matsuoka, Kohei Kaku
Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes Mellitus. Biomedicines 10 (4) (2022)
Tomohiko Kimura, Kohei Kaku
Clinical relevance of dual agonist of glucagon and glucagon-like peptide-1 receptors to achieve functional restoration of first- and second-phase insulin secretion. Journal of diabetes investigation 13 (8) (2022)
Hideaki Kaneto, Tomohiko Kimura, Atsushi Obata, Masashi Shimoda, Kohei Kaku
Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History. International journal of molecular sciences 22 (5) (2021)
Hideaki Kaneto, Tomohiko Kimura, Masashi Shimoda, Atsushi Obata, Junpei Sanada, Yoshiro Fushimi, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku
Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: "The Earlier, the Better" in Therapy with Incretin-Based Medicine. International journal of molecular sciences 22 (15) (2021)
Tomohiko Kimura, Hideaki Kaneto
Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus. Journal of diabetes investigation (2021)
Tomohiko Kimura, Kohei Kaku
New prospects for incretin-related drugs in the treatment of type 2 diabetes. Journal of diabetes investigation 12 (7) (2020)
Tomoe Kinoshita, Masashi Shimoda, Koji Nakashima, Yoshiro Fushimi, Yurie Hirata, Akihito Tanabe, Fuminori Tatsumi, Hidenori Hirukawa, Junpei Sanada, Kenji Kohara, Shintaro Irie, Tomohiko Kimura, Yoshiko Nakamura, Momoyo Nishioka, Atsushi Obata, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study. Journal of diabetes investigation 11 (6) (2020)
Tomohiko Kimura, Yoshiro Fushimi, Hiroaki Hayashi, Fuminori Tatsumi, Yukiko Kanda-Kimura, Masashi Shimoda, Hidenori Hirukawa, Junpei Sanada, Atsushi Obata, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Insulin allergy brought out 8 years after starting insulin therapy in a subject with type 1 diabetes mellitus. Acta diabetologica 57 (8) (2020)
Tomoe Kinoshita, Shinji Kamei, Yoshiko Nakamura, Masashi Shimoda, Takatoshi Anno, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Fuminori Tatsumi, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome. Journal of diabetes investigation 9 (6) (2018)
Koji Nakashima, Hideaki Kaneto, Masashi Shimoda, Tomohiko Kimura, Kohei Kaku
Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism. Scientific reports 8 (1) (2018)
Shuhei Nakanishi, Hidenori Hirukawa, Masashi Shimoda, Fuminori Tatsumi, Kenji Kohara, Atsushi Obata, Tomohiko Kimura, Seizo Okauchi, Tomoe Kinoshita, Junpei Sanada, Yoshiro Fushimi, Momoyo Nishioka, Akiko Mizoguchi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data. Journal of diabetes investigation 10 (2) (2018)
Tomohiko Kimura, Atsushi Obata, Masashi Shimoda, Ikki Shimizu, Gabriela da Silva Xavier, Seizo Okauchi, Hidenori Hirukawa, Kenji Kohara, Tomoatsu Mune, Saeko Moriuchi, Arudo Hiraoka, Kentaro Tamura, Genta Chikazawa, Atsuhisa Ishida, Hidenori Yoshitaka, Guy A Rutter, Kohei Kaku, Hideaki Kaneto
Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity. Scientific reports 8 (1) (2018)
Tomohiko Kimura, Junpei Sanada, Masashi Shimoda, Hidenori Hirukawa, Yoshiro Fushimi, Momoyo Nishioka, Tomoe Kinoshita, Seizo Okauchi, Atsushi Obata, Kenji Kohara, Fuminori Tatsumi, Shinji Kamei, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension. Journal of diabetes investigation 9 (4) (2017)